Sumitomo Pharma Co Ltd (OTCPK:DNPUF)
$ 4.3 0 (0%) Market Cap: 1.52 Bil Enterprise Value: 3.31 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 64/100

Full Year 2022 Sumitomo Pharma Co Ltd Earnings Presentation Transcript

May 16, 2022 / NTS GMT
Release Date Price: $9.69

May 16, 2022 / NTS GMT
Presentation
May 16, 2022 / NTS GMT

=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Pharma Co., Ltd. - CEO, President & Representative Director
* Miwako Harada
Sumitomo Pharma Co., Ltd. - Senior Director of Corporate Communications
* Toru Kimura
Sumitomo Pharma Co., Ltd. - Executive VP & Representative Director
* Yoshiharu Ikeda
Sumitomo Pharma Co., Ltd. - Senior Exe. Officer of Cancer, Modality & Drug Research Div., Head of Japan Busi Unit and Director

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot